In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AFFYMETRIX/MOLECULAR DYNAMICS MICROCHIP-BASED DNA DIAGNOSTIC DEVICE

This article was originally published in The Gray Sheet

Executive Summary

AFFYMETRIX/MOLECULAR DYNAMICS MICROCHIP-BASED DNA DIAGNOSTIC DEVICE will be developed first for use in detecting drug-resistant strains of HIV, Affymetrix said Oct. 24. The joint venture partners have received a cooperative $31.5 mil., five-year grant from the National Institute of Standards and Technology's (NIST) Advanced Technology Program (ATP) to develop miniaturized integrated nucleic acid diagnostic (MIND) devices and readers (MIND Readers) "suitable for the rapid and cost effective diagnosis of a wide variety of diseases in a hospital, clinic or doctor's office setting," Affymetrix explained.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002987

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel